COBAS 8000 C 502 MODULE C502

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-08-30 for COBAS 8000 C 502 MODULE C502 manufactured by Roche Diagnostics.

Event Text Entries

[84009790] This event occurred in (b)(6). Unique identifier (udi)#: (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[84009931] The customer complained of erroneous results for 1 patient? S urine sample tested for albt2 tina-quant albumin gen. 2 (albt2) on a cobas 8000 c 502 module. The initial albt2 result was 318. 8 mg/l with a prozone value of 1338. A flag was not generated. This result did not fit the clinical condition of the patient so the customer decided to dilute the sample and repeat it. The result was 2993. 3 mg/l with a prozone value of 3087. A flag was not generated. The repeat result was believed to be correct. There was no allegation that an adverse event occurred. The albt2 reagent lot number was 219743 with an expiration date of 11/30/2018. The customer has set the prozone limit is set as between (-)32000 and 1300. A prozone alarm will occur if the prozone value is between these values. The prozone values related to the customer's complaint were both greater than 1300, therefore, there was no alarm. The reaction kinetics provided by the customer appear strange for the result of 318. 8 mg/l. The repeat result of 2993. 3 was performed in decreased mode and was therefore diluted. It appears that an unknown interference or high dose hook effect was diluted out causing the high prozone value. Product labeling states that when using the prozone check, no false result without a flag was observed up to an albumin concentration of 40,000 mg/l. A specific root cause for the result of 318. 8 mg/l was not identified. Additional information was requested for investigation of this result but could not be provided. The analyzer performs as it should in relation the to the prozone limit as set by the customer.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1823260-2017-01852
MDR Report Key6829701
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-08-30
Date of Report2017-08-30
Date of Event2017-06-21
Date Mfgr Received2017-06-22
Date Added to Maude2017-08-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag0
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1HITACHI HIGH TECH CORP.
Manufacturer Street882 ICHIGE HITACHINAKA NA
Manufacturer CityIBARAKI 312-8504
Manufacturer CountryJA
Manufacturer Postal Code312-8504
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Sequence Number: 0

Brand NameCOBAS 8000 C 502 MODULE
Generic NameCLINICAL CHEMISTRY ANALYZER
Product CodeCJW
Date Received2017-08-30
Model NumberC502
Catalog NumberASKU
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrR
Device Sequence No0
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457

Device Sequence Number: 1

Brand NameCOBAS 8000 C 502 MODULE
Generic NameCLINICAL CHEMISTRY ANALYZER
Product CodeJJE
Date Received2017-08-30
Model NumberC502
Catalog NumberASKU
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2017-08-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.